Medica Sur S.A.B. de c.v. operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medica Sur S.A.B. de c.v. with three other
health care providers in Latin America:
Hapvida Participacoes e Investimentos SA
sales of 8.55 billion Brazilian Reals [US$1.54 billion]
of which 100%
was Health Sector),
Instituto de Diagnostico SA
(139.36 billion Chilean Pesos [US$172.80 million]
of which 70%
was Hospitalization), and
Clinica Las Condes SA
based in CHILE
(212.27 billion Chilean Pesos [US$263.21 million]
of which 67%
During the third
quarter of 2021, sales at Medica Sur S.A.B. de c.v. totalled
1.49 billion Mexican Pesos.
an increase of 21.1%
from the 1.23 billion Mexican Pesos in sales at the company during the third quarter of 2020.
During the first three quarters of 2021, sales totalled 4.31 billion Mexican Pesos, which is
than through the first three
quarters of 2020.
Medica Sur S.A.B. de c.v. reported sales of 4.47 billion Mexican Pesos (US$220.94 million)
December of 2020.
increase of 20.8%
versus 2019, when the company's sales were 3.70 billion Mexican Pesos.
Sales at Medica Sur S.A.B. de c.v. have increased during each of the previous five years
(and since 2015, sales have increased a total of 96%).
Sales of Diagnosis saw an increase
33.8% in 2020, from
2.00 billion Mexican Pesos to 2.68 billion Mexican Pesos.
Not all segments of Medica Sur S.A.B. de c.v. experienced an increase in sales in 2020:
sales of Other fell 16.6% to 111.63 million Mexican Pesos.
(However, this segment's sales were only a very small portion of the company's overall sales).